selected scholarly activity
-
conferences
- Organ at Risk Dose Constraints in Stereotactic Ablative Radiotherapy: A Systematic Review of Active Clinical Trials. International Journal of Radiation Oncology Biology Physics. e477-e477. 2021
- Th17 Recruitment and Interferon Pathway Activation in Oral Chronic Graft-Versus-Host Disease Tissues. Transplantation and Cellular Therapy. S90-S91. 2016
- Emerging technologies for oral diagnostics: lessons from chronic graft-versus-host disease. Proceedings of SPIE - The International Society for Optical Engineering. 2013
- Chronic Graft-Versus-Host Disease (cGVHD) Patients with Bronchiolitis Obliterans Syndrome (BOS) Have Worse Clinical Manifestations and Severity of cGVHD with More Impairment in Self-Assessed Physical and Mental Health than cGVHD Patients without BOS. Blood. 1939-1939. 2012
- Dual antiangiogenic therapy using lenalidomide and bevacizumab with docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 2012
-
journal articles
- Oral Health-Related Quality of Life in Rare Disorders of Congenital Facial Weakness. International Journal of Environmental Research and Public Health. 21:615-615. 2024
- Cluster analysis to identify the profiles of individuals with compromised bone health versus unfortunate wrist fractures within the Canadian Longitudinal Study of Aging (CLSA) database. Archives of Osteoporosis. 18:148. 2023
- Barriers to oral care: a cross-sectional analysis of the Canadian longitudinal study on aging (CLSA). BMC Oral Health. 23:294. 2023
- Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID). PLoS ONE. 17:e0266663-e0266663. 2022
- Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease. iScience. 25:103592-103592. 2022
- Clustering of obesity-related characteristics: A latent class analysis from the Canadian Longitudinal Study on Aging. Preventive Medicine. 153:106739-106739. 2021
- Reliability and Minimal Detectable Change Values for Performance-Based Measures of Physical Functioning in the Canadian Longitudinal Study on Aging. The journals of gerontology. Series A, Biological sciences and medical sciences. 76:2030-2038. 2021
- Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials. Practical Radiation Oncology. 11:e355-e365. 2021
- Body mass index, waist circumference, waist-to-hip ratio, and body fat in relation to health care use in the Canadian Longitudinal Study on Aging. International Journal of Obesity. 45:666-676. 2021
- Modifiable factors related to life-space mobility in community-dwelling older adults: results from the Canadian Longitudinal Study on Aging. BMC Geriatrics. 20:35. 2020
- A comprehensive analysis of factors related to lung function in older adults: Cross-sectional findings from the Canadian Longitudinal Study on Aging. Respiratory Medicine. 173:106157-106157. 2020
- Oral Health, Diet, and Frailty at Baseline of the Canadian Longitudinal Study on Aging. Journal of The American Geriatrics Society. 68:959-966. 2020
- Self‐reported oral health at baseline of the Canadian Longitudinal Study on Aging. Community Dentistry and Oral Epidemiology. 48:72-80. 2020
- Dental abnormalities in individuals with pathogenic germline variation in DICER1. American Journal of Medical Genetics, Part A. 179:1820-1825. 2019
- Oral Health in Healthy Aging. Journal of The American Geriatrics Society. 66:439-440. 2018
- Cephalometry in adults and children with neurofibromatosis type 1: Implications for the pathogenesis of sphenoid wing dysplasia and the “NF1 facies”. European Journal of Medical Genetics. 58:584-590. 2015
- Oral Disease Profiles in Chronic Graft versus Host Disease. Journal of Dental Research. 94:547-554. 2015
- NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD. Bone Marrow Transplantation. 49:1513-1520. 2014
- Malnutrition in patients with chronic GVHD. Bone Marrow Transplantation. 49:1300-1306. 2014
- Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures. Bone Marrow Transplantation. 49:116-121. 2014
- Oral chronic graft‐versus‐host disease: current pathogenesis, therapy, and research. Oral Diseases. 19:327-346. 2013
- National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis. Transplantation and Cellular Therapy. 19:632-639. 2013
- Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease. Journal of Clinical Immunology. 32:1390-1399. 2012
- Denosumab treatment for fibrous dysplasia. Journal of Bone and Mineral Research. 27:1462-1470. 2012
- Oral Chronic Graft-vs.-Host Disease Characterization Using the NIH Scale. Journal of Dental Research. 91:S45-S51. 2012
- Craniofacial and dental findings in cystinosis. Oral Diseases. 16:488-495. 2010
- Enamel defects and salivary methylmalonate in methylmalonic acidemia. Oral Diseases. 15:196-205. 2009
- Modification of the Risk of Mortality from Pneumonia with Oral Hygiene Care. Journal of The American Geriatrics Society. 56:1601-1607. 2008
- Salivary Procalcitonin and Periodontitis in Diabetes. Journal of Dental Research. 87:630-634. 2008